Screening ABL1 kinase domain mutations in patients with de novo Philadelphia chromosome-positive (Ph plus ) acute lymphoblastic leukemia (ALL)

被引：1
|
作者：
Li, He [1 ]
Zhang, Wanhua [1 ]
Yi, Dongni [1 ]
Ye, Yuanxin [2 ]
Xiao, Xueqiu [3 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Hematol, Hematol Res Lab, 37 Guo Xue Xiang, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu, Peoples R China
[3] Sichuan Univ, West China Sch Med, Chengdu, Peoples R China
来源：
LEUKEMIA & LYMPHOMA | 2017年 / 58卷 / 04期
关键词：
CHRONIC MYELOID-LEUKEMIA; BCR-ABL; CLINICAL IMPACT; IMATINIB; RESISTANT; THERAPY;
D O I：
10.1080/10428194.2016.1225205
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1005 / 1007
页数：3
相关论文
共 50 条
  • [31] Drug Resistance and BCR-ABL Kinase Domain Mutations in Philadelphia Chromosome- Positive Acute Lymphoblastic Leukemia From the Imatinib to the Second- Generation Tyrosine Kinase Inhibitor Era
    Soverini, Simona
    De Benedittis, Caterina
    Papayannidis, Cristina
    Paolini, Stefania
    Venturi, Claudia
    Iacobucci, Ilaria
    Luppi, Mario
    Bresciani, Paola
    Salvucci, Marzia
    Russo, Domenico
    Sica, Simona
    Orlandi, Ester
    Intermesoli, Tamara
    Gozzini, Antonella
    Bonifacio, Massimiliano
    Rigolin, Gian Matteo
    Pane, Fabrizio
    Baccarani, Michele
    Cavo, Michele
    Martinelli, Giovanni
    CANCER, 2014, 120 (07) : 1002 - 1009
  • [32] Comparing de novo chronic myeloid leukemia in blastic phase with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation
    Okada, Yosuke
    Tachi, Noriaki
    Shimazu, Yutaka
    Murata, Makoto
    Nishiwaki, Satoshi
    Onishi, Yasushi
    Jinguji, Atsushi
    Uchida, Naoyuki
    Tanaka, Masatsugu
    Hasegawa, Yuta
    Ito, Ayumu
    Kako, Shinichi
    Nishida, Tetsuya
    Onodera, Koichi
    Sawa, Masashi
    Nakamae, Hirohisa
    Toyosaki, Masako
    Kanda, Yoshinobu
    Onizuka, Makoto
    Fukuda, Takahiro
    Ohbiki, Marie
    Atsuta, Yoshiko
    Arai, Yasuyuki
    Tachibana, Takayoshi
    CANCER, 2025, 131 (01)
  • [33] Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia
    Akahoshi, Yu
    Nishiwaki, Satoshi
    Mizuta, Shuichi
    Ohashi, Kazuteru
    Uchida, Naoyuki
    Tanaka, Masatsugu
    Fukuda, Takahiro
    Ozawa, Yukiyasu
    Takahashi, Satoshi
    Onizuka, Makoto
    Shiratori, Souichi
    Nakamae, Hirohisa
    Kanda, Yoshinobu
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Kako, Shinichi
    CANCER SCIENCE, 2019, 110 (10) : 3255 - 3266
  • [34] Cost-effectiveness analysis of dasatinib versus imatinib in pediatric philadelphia chromosome-positive acute lymphoblastic leukemia patients in China
    Cao, Wang
    Yu, Yuncui
    Qiu, Yingpeng
    Liu, Lu
    Zhang, Hao
    Shi, Liwei
    Xiao, Yue
    Jia, Lulu
    Zhang, Ruidong
    Wang, Xiaoling
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [35] BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
    Zabriskie, Matthew S.
    Eide, Christopher A.
    Tantravahi, Srinivas K.
    Vellore, Nadeem A.
    Estrada, Johanna
    Nicolini, Franck E.
    Khoury, Hanna J.
    Larson, Richard A.
    Konopleva, Marina
    Cortes, Jorge E.
    Kantarjian, Hagop
    Jabbour, Elias J.
    Kornblau, Steven M.
    Lipton, Jeffrey H.
    Rea, Delphine
    Stenke, Leif
    Barbany, Gisela
    Lange, Thoralf
    Hernandez-Boluda, Juan-Carlos
    Ossenkoppele, Gert J.
    Press, Richard D.
    Chuah, Charles
    Goldberg, Stuart L.
    Wetzler, Meir
    Mahon, Francois-Xavier
    Etienne, Gabriel
    Baccarani, Michele
    Soverini, Simona
    Rosti, Gianantonio
    Rousselot, Philippe
    Friedman, Ran
    Deininger, Marie
    Reynolds, Kimberly R.
    Heaton, William L.
    Eiring, Anna M.
    Pomicter, Anthony D.
    Khorashad, Jamshid S.
    Kelley, Todd W.
    Baron, Riccardo
    Druker, Brian J.
    Deininger, Michael W.
    O'Hare, Thomas
    CANCER CELL, 2014, 26 (03) : 428 - 442
  • [36] Treatment Selection for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors
    Ma, Yingying
    Zhang, Quanchao
    Kong, Peiyan
    Xiong, Jingkang
    Zhang, Xi
    Zhang, Cheng
    CHEMOTHERAPY, 2019, 64 (02) : 81 - 93
  • [37] Current treatment options for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Stock, Wendy
    LEUKEMIA & LYMPHOMA, 2010, 51 (02) : 188 - 198
  • [38] Imatinib mesylate in combination with chemotherapy in four children with de novo and advanced stage Philadelphia chromosome-positive acute lymphoblastic leukemia
    Luis Fuster, Jose
    Bermudez, Mar
    Galera, Ana
    Esther Llinares, Maria
    Calle, Doris
    Jose Ortuno, Francisco
    HAEMATOLOGICA, 2007, 92 (12) : 1723 - 1724
  • [39] Tyrosine kinase inhibitors and reduced-dose chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia
    Wu, Chunping
    Zeng, Mengting
    Chen, Yuanzhong
    Wu, Yong
    HEMATOLOGY, 2022, 27 (01) : 1032 - 1040
  • [40] Effect of the tyrosine kinase inhibitors on the growth in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: a case-control study
    Cai, Jiaoyang
    Liu, Hu
    Chen, Yumei
    Yu, Jie
    Gao, Ju
    Jiang, Hua
    Zhai, Xiaowen
    Ju, Xiuli
    Wu, Xuedong
    Wang, Ningling
    Tian, Xin
    Liang, Changda
    Fang, Yongjun
    Zhou, Fen
    Li, Hong
    Sun, Lirong
    Yang, Liangchun
    Guo, Jing
    Liu, Aiguo
    Li, Chi-kong
    Zhu, Yiping
    Tang, Jingyan
    Yang, Jun J.
    Shen, Shuhong
    Cheng, Cheng
    Pui, Ching-Hon
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 38
12345